|
|
Laboratory Corporation Of America Holdings (LH) |
|
|
|
| |
LH's Revenue Growth by Quarter and Year
Laboratory Of America Holdings's Revenue results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| LH Revenue (in millions $) |
FY 2021 |
FY 2020 |
FY 2019 |
FY 2018 |
| IV Quarter |
December |
-
|
4,489.80
|
2,953.40
|
2,787.50
|
| III Quarter |
September |
4,062.60
|
3,896.10
|
2,928.50
|
2,831.30
|
| II Quarter |
June |
3,840.70
|
2,768.80
|
2,881.70
|
2,866.30
|
| I Quarter |
March |
4,161.50
|
2,823.80
|
2,791.20
|
2,848.30
|
| FY |
|
12,064.80
|
13,978.50
|
11,554.80
|
11,333.40
|
| LH Revenue third quarter 2021 Y/Y Growth Comment |
Laboratory Corporation Of America Holdings achieved in the third quarter, above Company average Revenue improvement of 4.27% year on year, to $ 4,062.60 millions.
Looking into third quarter results within Medical Laboratories industry 9 other companies have achieved higher Revenue growth. While Laboratory Corporation Of America Holdings' s Revenue increase of 4.27% ranks overall at the positon no. 878 in the third quarter.
|
| LH Revenue ( Y/Y Growth %) |
2021
|
2020 |
2019 |
2018 |
| IV Quarter |
December |
- |
52.02 % |
5.95 % |
4.98 % |
| III Quarter |
September |
4.27 % |
33.04 % |
3.43 % |
11.34 % |
| II Quarter |
June |
38.71 % |
-3.92 % |
0.54 % |
17.14 % |
| I Quarter |
March |
47.37 % |
1.17 % |
-2 % |
17.96 % |
| FY |
|
- |
20.98 % |
1.95 % |
12.66 % |
LH Revenue (Quarter on Quarter Growth %) |
2021
|
2020 |
2019 |
2018 |
| IV Quarter |
December |
- |
15.24 % |
0.85 % |
-1.55 % |
| III Quarter |
September |
5.78 % |
40.71 % |
1.62 % |
-1.22 % |
| II Quarter |
June |
-7.71 % |
-1.95 % |
3.24 % |
0.63 % |
| I Quarter |
March |
-7.31 % |
-4.39 % |
0.13 % |
7.27 % |
| FY (Year on Year) |
|
- |
20.98 % |
1.95 % |
12.66 % |
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 12.35 % |
2.06 % |
-29.4 % |
| (Dec 31 2020) |
|
(Sep. 30, 2015) |
|
|
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 12.35 % |
2.06 % |
-29.4 % |
| (Dec 31 2020) |
|
(Sep. 30, 2015) |
|
| Revenue by Quarter for the Fiscal Years 2018, 2019, 2020, 2021 |
Laboratory Of America Holdings's Q/Q Revenue Growth
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 40.71 % |
2.73 % |
-7.71 % |
| (Sep 30 2020) |
|
|
| LH's III. Quarter Q/Q Revenue Comment |
Laboratory Corporation Of America Holdings achieved in the III. Quarter 2021 above company average sequential Revenue increase of 5.78%, to $ 4,062.60 millions, from $3,840.70 millions in the second quarter.
Within Medical Laboratories industry 4 other companies have achieved higher Revenue quarter on quarter growth. While Laboratory Of America Holdings's Revenue growth quarter on quarter, overall rank is 379. |
|
|
|
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 40.71 % |
2.73 % |
-7.71 % |
| (Sep 30 2020) |
|
|
| LH's III. Quarter Q/Q Revenue Comment |
Laboratory Corporation Of America Holdings achieved in the III. Quarter 2021 above company average sequential Revenue increase of 5.78%, to $ 4,062.60 millions, from $3,840.70 millions in the second quarter.
Within Medical Laboratories industry 4 other companies have achieved higher Revenue quarter on quarter growth. While Laboratory Of America Holdings's Revenue growth quarter on quarter, overall rank is 379. |
|
Laboratory Of America Holdings's 12 Months Revenue Growth Year on Year
Revenue TTM Growth |
12 Months Ending
(Sep 30 2021) |
12 Months Ending
(Jun 30 2021) |
12 Months Ending
(Mar 31 2021) |
12 Months Ending
(Dec 31 2020) |
12 Months Ending
(Sep 30 2020) |
| Cumulative Revenue 12 Months Ending |
$ 16,554.60 |
$ 16,388.10 |
$ 15,316.20 |
$ 13,978.50 |
$ 12,442.10 |
| Y / Y Revenue Growth (TTM) |
33.05 % |
42.82 % |
32.18 % |
20.98 % |
9.25 % |
| Year on Year Revenue Growth Overall
Ranking |
# 213 |
# 600 |
# 214 |
# 340 |
# 1048 |
| Seqeuential Revenue Change (TTM) |
1.02 % |
7 % |
9.57 % |
12.35 % |
8.43 % |
| Seq. Revenue Growth (TTM) Overall
Ranking |
# 2749 |
# 1684 |
# 791 |
# 623 |
# 595 |
| Cumulative Revenue growth
Comment |
Assuming the Laboratory Of America Holdings's fiscal year would have ended in Sep 30 2021, Laboratory Of America Holdings would have reprted above average annual Revenue rise of 33.05% year on year, of $ 16,555 millions.
This marks a slow-down of the companys growth trends and from the 42.82% increase in Jun 30 2021.
Within the Healthcare sector 30 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 213, from total ranking in previous quarter at 600. |
| Revenue TTM Q/Q Growth Statistics |
| High |
Average |
Low |
12.35 % |
2.06 % |
-29.4 % |
| (Dec 31 2020) |
|
|
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
47.24 % |
11.33 % |
1.62 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 28 |
| Sector |
# 378 |
| S&P 500 |
# 2740 |
|
| Cumulative Revenue growth
Comment |
Assuming the Laboratory Of America Holdings's fiscal year would have ended in Sep 30 2021, Laboratory Of America Holdings would have reprted above average annual Revenue rise of 33.05% year on year, of $ 16,555 millions.
This marks a slow-down of the companys growth trends and from the 42.82% increase in Jun 30 2021.
Within the Healthcare sector 30 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 213, from total ranking in previous quarter at 600. |
| Revenue TTM Q/Q Growth Statistics |
| High |
Average |
Low |
12.35 % |
2.06 % |
-29.4 % |
| (Dec 31 2020) |
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
47.24 % |
11.33 % |
1.62 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 28 |
| Sector |
# 378 |
| S&P 500 |
# 2740 |
|
7.40%